SlowBull
The Business Brief SATURDAY, 8 AUGUST 2026
← All stories
Markets

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

1 source ·1 article ·Aug 5, 16:52 UTC Global Partners

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

Covered by 1 outlet

Marketwatch 1

All coverage · 1 article

MarketWatch Top Stories ·Aug 5, 16:52 UTC

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.